News

Conditas will represent the Melbourne and Shanghai based company as its agent for business development and sales of services in the US. The Conditas Group Jr. founder and

The formulations include Cannabis Science CT-1 and Cannabis Science MT-1, indicated for medical marijuana patients. Cannabis Science MT-1 is produced by Marisol Therapeutics, while Cannabis Science CT-1 is

Under the collaboration, to a target drug candidate selected by Ono, BioSeek is utilizing its proprietary BioMAP platform to conduct phenotypic screening, hit identification, lead optimization and clinical

The funding is intended to help gain further insights on ceramic materials, to develop a technology platform for safe dosing of opioids. The project will make use of

The new range of bioreactors has been developed for fragile adherent cell culture applications on a large scale. The Integrity bioreactors support safe and cost-efficient large-scale (large volume)

MM-121 is a fully human monoclonal antibody that targets ErbB3. The trial is intended to assess the safety and pharmacokinetics of MM-121 when administered in combination with separate

One of the achievements includes successful scale up of the Plasma Protein Purification System (PPPSTM) manufacturing platform in CNBG’s Wuhan facility. The new milestone demonstrates the robustness of

Warfarin is an oral anticoagulant agent largely recommended for treatment and prevention of thromboembolism such as cardiogenic brain embolism and venous thrombosis. The new formulation is believed to

Lipitor is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL, triglycerides and to increase HDL cholesterol. As per the deal, Pfizer manufactures and supplies